Ursodeoxycholic acid tablets are usually round, white to off-white, and may be film-coated. Imprint codes vary by manufacturer; common markings include “300 UDCA” or a manufacturer’s logo.
Yes, but carry the prescription label and a copy of the prescribing information. Some countries require documentation for medicines that affect liver function, so checking the destination’s import rules beforehand is advisable.
UDCA is not a prohibited substance on the World Anti-Doping Agency (WADA) list. However, athletes should disclose all medications to their governing body to avoid inadvertent violations.
Obeticholic acid is a newer bile-acid receptor agonist reserved for patients who inadequately respond to UDCA. UDCA remains first-line because of its long-term safety record, while obeticholic acid may carry a higher risk of pruritus and liver enzyme elevations.
No specific diet is required, but a balanced, low-fat diet supports overall liver health. Excessive fatty meals can exacerbate cholestasis, so moderation is prudent.
Contact your prescriber promptly. They may advise restarting at a lower dose and monitoring liver enzymes to ensure safety.
Mild to moderate renal impairment does not usually require dose adjustment, but regular kidney function tests are recommended to detect any changes.
It is occasionally prescribed off-label for this purpose, but evidence is limited. Discuss the potential benefits and risks with a healthcare professional before initiating therapy.
Patients often observe a gradual decline in alkaline phosphatase and bilirubin over 3-6 months of consistent therapy, though individual responses vary.
Inactive ingredients may include lactose, starch, or magnesium stearate, depending on the manufacturer. If you have known allergies, review the product’s excipient list or consult a pharmacist.
Ursodeoxycholic Acid (UDCA) is a bile-acid derivative used to treat several liver-related conditions. This article covers Ursodeoxycholic Acid, available as a generic medication and marketed under brand names such as Ursofalk, Urso, and Ursodiol. In the United Kingdom it is a prescription-only medicine (POM) supplied as a 300 mg pill.
Ursodeoxycholic Acid is a naturally occurring secondary bile acid that influences the composition and flow of bile. Its primary actions are:
These mechanisms together lower the concentration of harmful bile acids, promote the dissolution of small cholesterol gallstones, and slow the progression of cholestatic liver diseases.
Ursodeoxycholic Acid is approved by the Medicines and Healthcare products Regulatory Agency (MHRA) for the following indications:
The medication is typically prescribed to adults; pediatric use is limited to specific cholestatic disorders under specialist supervision.
Off-label use requires medical supervision and individualized risk assessment.
Absolute Contraindications
Known hypersensitivity to ursodeoxycholic acid or any tablet excipients.
Complete biliary obstruction (e.g., obstructive jaundice) where bile flow cannot be restored.
Relative Contraindications
Severe hepatic impairment (Child-Pugh C) - dose adjustment and close monitoring are advised.
Pregnant or breastfeeding women - limited safety data; use only if the potential benefit outweighs risk.
Special Populations
Elderly: Renal function should be assessed, but no routine dose reduction is required.
Renal Impairment: Monitor serum creatinine; no specific dosage change is mandated for mild to moderate dysfunction.
If any of these conditions apply, discuss alternatives with a healthcare professional.
These effects are generally mild and may resolve without intervention. If they persist, contact a clinician.
If specific interaction data for a co-medication is unavailable, patients should inform their pharmacist or prescriber of all current medicines, supplements, and herbal products.
If abnormal results or worsening symptoms occur, dosage adjustment or alternative therapy may be considered.
This article provides educational information about Ursodeoxycholic Acid and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
